205 followers
Thrilled to share our experience in conversion therapy in dMMR/MSI-H CRC with pembrolizumab 😁, including oligometastatic disease ❗. The best treatment scheme, number of cycles needed or organ-preservation strategies need to be addressed 🔍 https://t.co/F